Daily News Podcast

MDedge Daily News: Which diabetes drug boosts survival best?


 

Which diabetes drug boosts survival best? Community cancer clinics keep closing. A champion arises among oral anticoagulants. And there’s new promise in early-stage lung cancer.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

MDedge Daily News: How European data privacy rules may cost you
MDedge Internal Medicine
Hope and hype: Inside the push for wearable diabetes technology
MDedge Internal Medicine
Sensitivity of vibration-based neuropathy detectors varies widely
MDedge Internal Medicine
Being overweight as a child increases the risk of developing diabetes
MDedge Internal Medicine
Clearer picture emerging of renal impact of SGLT2s
MDedge Internal Medicine
Diabetes from checkpoint inhibitors probably means lifelong insulin
MDedge Internal Medicine
Cardiovascular risk in type 2 diabetes: Patients are often clueless
MDedge Internal Medicine
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Internal Medicine
FDA approves marketing for retinal imaging device that uses artificial intelligence
MDedge Internal Medicine
VIDEO: Meta-analysis: Mortality, safety data may favor SGLT2 inhibitors in T2DM
MDedge Internal Medicine